Integrated delivery of HIV and tuberculosis services in sub-Saharan Africa: a systematic review (Q37950537)

25 August 2017

Integrated delivery of HIV and tuberculosis services in sub-Saharan Africa: a systematic review (English)

1 reference

25 August 2017

0 references

0 references

0 references

1 reference

3

James Macinko

1 reference

25 August 2017

Jennifer Uyei

1

1 reference

PubMed ID

22035614

25 August 2017

David Coetzee

series ordinal

2

1 reference

PubMed ID

22035614

25 August 2017

Sally Guttmacher

series ordinal

4

1 reference

25 August 2017

1 November 2011

1 reference

Lancet Infectious Diseases

25 August 2017

1 reference

25 August 2017

11

1 reference

25 August 2017

11

1 reference

25 August 2017

855-867

1 reference

HIV infection-associated tuberculosis: the epidemiology and the response

25 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970145-1

7 January 2021

Successful integration of tuberculosis and HIV treatment in rural South Africa: the Sizonq'oba study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970145-1

7 January 2021

Clinical management of tuberculosis in the context of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970145-1

7 January 2021

Implementation issues in tuberculosis/HIV program collaboration and integration: 3 case studies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970145-1

7 January 2021

Tuberculosis and HIV-Needed: A New Paradigm for the Control and Management of Linked Epidemics

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970145-1

7 January 2021

Integrating tuberculosis and HIV care in the primary care setting in South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970145-1

7 January 2021

Preventing antiretroviral anarchy in sub-Saharan Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970145-1

7 January 2021

Re-thinking global health sector efforts for HIV and tuberculosis epidemic control: promoting integration of programme activities within a strengthened health system

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970145-1

7 January 2021

Global HIV/AIDS funding and health systems: Searching for the win-win

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970145-1

7 January 2021

Strengthening health systems at facility-level: feasibility of integrating antiretroviral therapy into primary health care services in lusaka, zambia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970145-1

7 January 2021

African AIDS beyond Mbeki: tripping into anarchy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970145-1

7 January 2021

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970145-1

7 January 2021

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970145-1

7 January 2021

Intensified tuberculosis case finding among HIV-Infected persons from a voluntary counseling and testing center in Addis Ababa, Ethiopia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970145-1

7 January 2021

Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970145-1

7 January 2021

Urine lipoarabinomannan assay for tuberculosis screening before antiretroviral therapy diagnostic yield and association with immune reconstitution disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970145-1

7 January 2021

Pulmonary tuberculosis among people living with HIV/AIDS attending care and treatment in rural northern Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970145-1

7 January 2021

Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970145-1

7 January 2021

Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970145-1

7 January 2021

Isoniazid tuberculosis preventive therapy in HIV-infected adults accessing antiretroviral therapy: a Botswana Experience, 2004-2006.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970145-1

7 January 2021

Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970145-1

7 January 2021

Assessing the accessibility of HIV care packages among tuberculosis patients in the Northwest Region, Cameroon

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970145-1

7 January 2021

The Côte d'Ivoire national HIV counseling and testing program for tuberculosis patients: implementation and analysis of epidemiologic data

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970145-1

7 January 2021

Efficacy and acceptability of rapid, point-of-care HIV testing in two clinical settings in Ghana

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970145-1

7 January 2021

Efficacy and safety of two dosages of cotrimoxazole as preventive treatment for HIV-infected Malawian adults with new smear-positive tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970145-1

7 January 2021

Acceptance of anti-retroviral therapy among patients infected with HIV and tuberculosis in rural Malawi is low and associated with cost of transport

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970145-1

7 January 2021

Voluntary counselling, HIV testing and adjunctive cotrimoxazole reduces mortality in tuberculosis patients in Thyolo, Malawi

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970145-1

7 January 2021

A pilot study of once-daily antiretroviral therapy integrated with tuberculosis directly observed therapy in a resource-limited setting

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970145-1

7 January 2021

A cluster-randomized trial of provider-initiated (opt-out) HIV counseling and testing of tuberculosis patients in South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970145-1

7 January 2021

South African TB nurses' experiences of provider-initiated HIV counseling and testing in the Eastern Cape Province: a qualitative study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970145-1

7 January 2021

Low HIV testing rates among tuberculosis patients in Kampala, Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970145-1

7 January 2021

Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Côte d'Ivoire: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970145-1

7 January 2021

Role of co-trimoxazole prophylaxis in reducing mortality in HIV infected adults being treated for tuberculosis: randomised clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970145-1

7 January 2021

Tuberculosis preventive therapy for HIV-infected people in sub-Saharan Africa is cost-effective

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970145-1

7 January 2021

Cost and enrollment implications of targeting different source population for an HIV treatment program

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970145-1

7 January 2021

Modelling the economic benefits of tuberculosis preventive therapy for people with HIV: the example of Zambia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970145-1

7 January 2021

Costs of measures to control tuberculosis/HIV in public primary care facilities in Cape Town, South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970145-1

7 January 2021

The real and the nominal? Making inflationary adjustments to cost and other economic data

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970145-1

7 January 2021

Yield of HIV-associated tuberculosis during intensified case finding in resource-limited settings: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970145-1

7 January 2021

The effect of human immunodeficiency virus type-1 on the infectiousness of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970145-1

7 January 2021

Negative sputum smear results in HIV-positive patients with pulmonary tuberculosis in Lusaka, Zambia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970145-1

7 January 2021

Incidence of tuberculosis and survival after its diagnosis in patients infected with HIV-1 and HIV-2.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970145-1

7 January 2021

Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970145-1

7 January 2021

The HIV-associated tuberculosis epidemic--when will we act?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970145-1

7 January 2021

Tuberculosis among health-care workers in low- and middle-income countries: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970145-1

7 January 2021

Tuberculosis infection control in resource-limited settings in the era of expanding HIV care and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970145-1

7 January 2021

Transmission of drug-susceptible and drug-resistant tuberculosis and the critical importance of airborne infection control in the era of HIV infection and highly active antiretroviral therapy rollouts

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970145-1

7 January 2021

Perceptions of tuberculosis patients on provider-initiated HIV testing and counseling--a study from south India

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970145-1

7 January 2021

Integrating HIV screening into routine health care in resource-limited settings

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970145-1

7 January 2021

Who starts antiretroviral therapy in Durban, South Africa?... not everyone who should

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970145-1

7 January 2021

Virological response to highly active antiretroviral therapy is unaffected by antituberculosis therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970145-1

7 January 2021

Virological follow-up of adult patients in antiretroviral treatment programmes in sub-Saharan Africa: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970145-1

7 January 2021

10.1016/S1473-3099(11)70145-1

Identifiers

DOI

1 reference

25 August 2017

1 reference

PubMed ID

22035614